Aug. 24 at 3:46 PM
$CAPR
Linda and
$CAPR are doing exactly what we've been suggesting they would...This extension is a massive milestone, the November date is encouraging, and I continue to believe they get approved (albeit Upper Limb, but at this point, I'm not sure indication matters).
For the rest on this list,
- Looking good, with
$MLTX being our biggest disconnect (and #2 Bio holding). Still expect re-rating once it settles.
-
$GUTS, our #1 Bio and #1 overall continues to find new footing. Several catalysts by the end of the year that could push this to
$4/share.
- ABCL,still riding high from their internal trial success (rather than just partner wins).
-DFTX still loaded.
-
$RGNX enters the conversation on this morning's overreaction dip. Should recover this "loss" sooner than later, but time will tell.
Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn.
Let's make some (more) money. Cheers!
$XBI
